Cresco Labs, Inc. (CL) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

272.19 k

Shareholding (Mar 2025)

FII

0.23%

Held by 24 FIIs

DII

99.77%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 6.77%

The company has been able to generate a Return on Capital Employed (avg) of 6.77% signifying low profitability per unit of total capital (equity and debt)

Negative results in Dec 24

Risky -

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CAD 564 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.75

Return on Equity

-5.51%

Price to Book

0.93

Revenue and Profits:

Net Sales:

226 Million

(Quarterly Results - Jun 2025)

Net Profit:

-19 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-23.57%

6 Months

71.43%

1 Year

-18.92%

2 Years

-52.19%

3 Years

-76.47%

4 Years

-88.44%

5 Years

-91.29%

Cresco Labs, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Cresco Labs Stock Soars 8.51%, Hits Intraday High of CAD 2.11

Cresco Labs, Inc. has seen a significant rise in its stock price, gaining 8.51% on October 15, 2025, with increased trading activity. While the company has outperformed the S&P/TSX 60 recently, it faces long-term challenges, including a decline in one-year performance and profitability issues.

Cresco Labs Hits Day High with 23.81% Surge in Intraday Performance

Cresco Labs, Inc. experienced significant stock activity on September 30, 2025, with a notable intraday high. Despite today's gains, the company has faced challenges in profitability and longer-term performance, reflected in its market capitalization and mixed results over various time frames.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

24.28%

EBIT Growth (5y)

19.61%

EBIT to Interest (avg)

0.30

Debt to EBITDA (avg)

2.88

Net Debt to Equity (avg)

0.72

Sales to Capital Employed (avg)

0.73

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.17%

ROCE (avg)

6.77%

ROE (avg)

0.45%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.11

EV to EBIT

9.19

EV to EBITDA

5.43

EV to Capital Employed

1.06

EV to Sales

1.18

PEG Ratio

Dividend Yield

ROCE (Latest)

11.57%

ROE (Latest)

-5.51%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 24 Foreign Institutions (0.23%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -4.79% vs -3.33% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 12.33% vs -3,750.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "226.40",
          "val2": "237.80",
          "chgp": "-4.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.60",
          "val2": "40.60",
          "chgp": "36.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.60",
          "val2": "22.40",
          "chgp": "-16.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.20",
          "val2": "-21.90",
          "chgp": "12.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "159.80%",
          "val2": "82.00%",
          "chgp": "7.78%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.63% vs -5.15% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 65.84% vs 13.63% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "992.30",
          "val2": "1,040.50",
          "chgp": "-4.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "241.70",
          "val2": "178.80",
          "chgp": "35.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "80.70",
          "val2": "85.40",
          "chgp": "-5.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.30",
          "val2": "-202.70",
          "chgp": "98.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-82.90",
          "val2": "-242.70",
          "chgp": "65.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "152.40%",
          "val2": "82.00%",
          "chgp": "7.04%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

226.40

237.80

-4.79%

Operating Profit (PBDIT) excl Other Income

55.60

40.60

36.95%

Interest

18.60

22.40

-16.96%

Exceptional Items

-13.80

0.00

Consolidate Net Profit

-19.20

-21.90

12.33%

Operating Profit Margin (Excl OI)

159.80%

82.00%

7.78%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -4.79% vs -3.33% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 12.33% vs -3,750.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

992.30

1,040.50

-4.63%

Operating Profit (PBDIT) excl Other Income

241.70

178.80

35.18%

Interest

80.70

85.40

-5.50%

Exceptional Items

-3.30

-202.70

98.37%

Consolidate Net Profit

-82.90

-242.70

65.84%

Operating Profit Margin (Excl OI)

152.40%

82.00%

7.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -4.63% vs -5.15% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 65.84% vs 13.63% in Dec 2023

All Annual Results

Company CV

About Cresco Labs, Inc.

Cresco Labs, Inc.

Other Agricultural Products

Cresco Labs Inc., formerly Randsburg International Gold Corp., is a cannabis operator in United States. The Company manufactures a suite of cannabis extracts and vape products. The Company is a processor and retailer of cannabis products with operations in six states, including Illinois, Ohio, Pennsylvania, Nevada, California and Arizona. It distributes its cannabis products to dispensaries.

Company Coordinates

Company Details

400 W ERIE ST SUITE 110 , CHICAGO IL : 60654

Tel: 1 312 9290993

http://www.crescolabs.com/

Registrar Details

Cresco Labs, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROCE of 6.77%

Negative results in Dec 24

Risky -

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Cresco Labs Stock Soars 8.51%, Hits Intraday High of CAD 2.11

Cresco Labs Hits Day High with 23.81% Surge in Intraday Performance

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Cresco Labs, Inc.

Company Coordinates